The Pharmaceutical Journal
Vol 269 No 7213 p278-281
31 August 2002

This page
Reprint
Photocopy

PDF* 70K

  Needle exchange
  Product names
  EHC
  Remuneration
  Compliance
  Type 2 diabetes
  The Profession
  Modernisation
  The Society

Letters to the Editor

Product names

Potential for error exists

From Mr D. R. Kaye, MRPharmS

I note that the long-acting Lantus insulin has been launched in the United Kingdom (PJ, 10 August, p189). All pharmacists should be aware of the potential for confusion with insulin lente, especially with hand-written prescriptions.

The Institute for Safe Medication Practice has reported two cases of errors in the United States associated with Lantus and lente being confused.

David Kaye
Swinton, Manchester

Send your letter to The Editor

Previous Topic (Needle exchange)
Next Topic (Emergency hormonal contraception)